{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:47:05Z","timestamp":1787028425257,"version":"build-2736575974"},"reference-count":99,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD099486"],"award-info":[{"award-number":["R01HD099486"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Pompe disease is a glycogen storage disease caused by a deficiency in acid \u03b1-glucosidase (GAA), a hydrolase necessary for the degradation of lysosomal glycogen. This deficiency in GAA results in muscle and neuronal glycogen accumulation, which causes respiratory insufficiency. Pompe disease mouse models provide a means of assessing respiratory pathology and are important for pre-clinical studies of novel therapies that aim to treat respiratory dysfunction and improve quality of life. This review aims to compile and summarize existing manuscripts that characterize the respiratory phenotype of Pompe mouse models. Manuscripts included in this review were selected utilizing specific search terms and exclusion criteria. Analysis of these findings demonstrate that Pompe disease mouse models have respiratory physiological defects as well as pathologies in the diaphragm, tongue, higher-order respiratory control centers, phrenic and hypoglossal motor nuclei, phrenic and hypoglossal nerves, neuromuscular junctions, and airway smooth muscle. Overall, the culmination of these pathologies contributes to severe respiratory dysfunction, underscoring the importance of characterizing the respiratory phenotype while developing effective therapies for patients.<\/jats:p>","DOI":"10.3390\/ijms21062256","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T13:04:04Z","timestamp":1585055044000},"page":"2256","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Respiratory Phenotype of Pompe Disease Mouse Models"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4245-8290","authenticated-orcid":false,"given":"Anna F.","family":"Fusco","sequence":"first","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Duke University, Durham, NC 27707, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5249-7176","authenticated-orcid":false,"given":"Angela L.","family":"McCall","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Duke University, Durham, NC 27707, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin S.","family":"Dhindsa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Duke University, Durham, NC 27707, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Duke University, Durham, NC 27707, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan","family":"Bailey","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Duke University, Durham, NC 27707, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda F.","family":"Kahn","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Duke University, Durham, NC 27707, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1775-1156","authenticated-orcid":false,"given":"Mai K.","family":"ElMallah","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Duke University, Durham, NC 27707, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,3,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/bj0860011","article-title":"Alpha-Glucosidase deficiency in generalized glycogenstorage disease (Pompe\u2019s disease)","volume":"86","author":"Hers","year":"1963","journal-title":"Biochem. J."},{"key":"ref_2","first-page":"304","article-title":"Over idiopathische hypertrophie van het hart","volume":"76","author":"Pompe","year":"1932","journal-title":"Ned Tijdschr Geneeskd"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2011.02.004","article-title":"Pompe disease: Design, methodology, and early findings from the Pompe Registry","volume":"103","author":"Byrne","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.jpeds.2004.01.053","article-title":"Pompe disease in infants and children","volume":"144","author":"Kishnani","year":"2004","journal-title":"J. Pediatr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1750-1172-8-90","article-title":"Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy","volume":"8","author":"Prater","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fnagi.2014.00177","article-title":"Pompe disease: From pathophysiology to therapy and back again","volume":"6","author":"Lim","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s13311-018-0655-y","article-title":"Pompe Disease: From Basic Science to Therapy","volume":"15","author":"Kohler","year":"2018","journal-title":"Neurotherapeutics"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1212\/01.wnl.0000252798.25690.76","article-title":"Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype","volume":"68","author":"Kroos","year":"2007","journal-title":"Neurology"},{"key":"ref_10","first-page":"132","article-title":"Biochemical, immunological, and cell genetic studies in glycogenosis type II","volume":"30","author":"Reuser","year":"1978","journal-title":"Am. J. Hum. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1067\/mpd.2000.107112","article-title":"Identification of two subtypes of infantile acid maltase deficiency","volume":"137","author":"Slonim","year":"2000","journal-title":"J. Pediatr."},{"key":"ref_12","first-page":"21","article-title":"Genetic heterogeneity in acid alpha-glucosidase deficiency","volume":"35","author":"Beratis","year":"1983","journal-title":"Am. J. Hum. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1542\/peds.112.2.332","article-title":"The natural course of infantile Pompe\u2019s disease: 20 original cases compared with 133 cases from the literature","volume":"112","author":"Hop","year":"2003","journal-title":"Pediatrics"},{"key":"ref_14","first-page":"3","article-title":"A molecular analysis of the GAA gene and clinical spectrum in 38 patients with Pompe disease in Japan","volume":"14","author":"Fukuhara","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ana.410380316","article-title":"Genotype-phenotype correlation in adult-onset acid maltase deficiency","volume":"38","author":"Wokke","year":"1995","journal-title":"Ann. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/mus.21025","article-title":"Clinical features of late-onset Pompe disease: A prospective cohort study","volume":"38","author":"Wokke","year":"2008","journal-title":"Muscle Nerve"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1469-8749.2003.tb00966.x","article-title":"Pompe disease and physical disability","volume":"45","author":"Haley","year":"2003","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.GIM.0000154301.76619.5C","article-title":"Infantile onset Pompe disease: A report of physician narratives from an epidemiologic study","volume":"7","author":"Marsden","year":"2005","journal-title":"Genet. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1212\/01.WNL.0000165979.46537.56","article-title":"Disease severity in children and adults with Pompe disease related to age and disease duration","volume":"64","author":"Hagemans","year":"2005","journal-title":"Neurology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","article-title":"Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk","volume":"113","author":"Kamphoven","year":"2004","journal-title":"Pediatrics"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.nurt.2008.08.009","article-title":"Therapeutic approaches in glycogen storage disease type II\/Pompe Disease","volume":"5","author":"Schoser","year":"2008","journal-title":"Neurotherapeutics"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00415-009-5275-3","article-title":"Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial","volume":"257","author":"Strothotte","year":"2010","journal-title":"J. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe\u2019s disease","volume":"362","author":"Clemens","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11910-011-0236-5","article-title":"Enzyme replacement therapy for Pompe disease","volume":"12","author":"Angelini","year":"2012","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.4187\/respcare.03419","article-title":"Late-onset Pompe disease with left-sided bronchomalacia","volume":"60","author":"Yang","year":"2015","journal-title":"Respir. Care"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1093\/hmg\/ddr174","article-title":"Pompe disease gene therapy","volume":"20","author":"Byrne","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1006\/mthe.2002.0580","article-title":"Correction of the enzymatic and functional deficits in a model of Pompe disease using adeno-associated virus vectors","volume":"5","author":"Fraites","year":"2002","journal-title":"Mol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ymthe.2005.01.012","article-title":"Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter","volume":"11","author":"Sun","year":"2005","journal-title":"Mol. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ana.24433","article-title":"Correcting Neuromuscular Deficits With Gene Therapy in Pompe Disease","volume":"78","author":"Todd","year":"2015","journal-title":"Ann. Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/1566523219666190621113807","article-title":"Reduction of Autophagic Accumulation in Pompe Disease Mouse Model Following Gene Therapy","volume":"19","author":"McCall","year":"2019","journal-title":"Curr. Gene. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/BF00685299","article-title":"Glycogenosis of the central nervous system in the cat","volume":"14","author":"Sandstrom","year":"1969","journal-title":"Acta Neuropathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/030098588302000307","article-title":"Generalized glycogen storage disease in Japanese quail (Coturnix coturnix japonica)","volume":"20","author":"Matsui","year":"1983","journal-title":"Vet. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/path.1711340403","article-title":"Infantile and late onset form of generalised glycogenosis type II in cattle","volume":"134","author":"Howell","year":"1981","journal-title":"J. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Seppala, E.H., Reuser, A.J., and Lohi, H. (2013). A nonsense mutation in the acid alpha-glucosidase gene causes Pompe disease in Finnish and Swedish Lapphunds. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0056825"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/icb.1977.11","article-title":"Generalized glycogenosis in beef shorthorn cattle--heterozygote detection","volume":"55","author":"Jolly","year":"1977","journal-title":"Aust. J. Exp. Biol. Med. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0021-9975(75)90092-4","article-title":"Generalized glycogen storage disease in sheep","volume":"85","author":"Manktelow","year":"1975","journal-title":"J. Comp. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02391186","article-title":"Glycogen storage diseases in animals and their potential value as models of human disease","volume":"6","author":"Walvoort","year":"1983","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ymgme.2007.07.009","article-title":"Pompe disease: Current state of treatment modalities and animal models","volume":"92","author":"Geel","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/(SICI)1096-9896(199911)189:3<416::AID-PATH445>3.0.CO;2-6","article-title":"Pathological features of glycogen storage disease type II highlighted in the knockout mouse model","volume":"189","author":"Bijvoet","year":"1999","journal-title":"J. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","article-title":"Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II","volume":"273","author":"Raben","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/mt.2013.96","article-title":"Intrapleural administration of AAV9 improves neural and cardiorespiratory function in Pompe disease","volume":"21","author":"Falk","year":"2013","journal-title":"Mol. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/mt.2013.282","article-title":"Sustained correction of motoneuron histopathology following intramuscular delivery of AAV in pompe mice","volume":"22","author":"Elmallah","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1152\/physiolgenomics.00075.2016","article-title":"Transcriptome assessment of the Pompe (Gaa\u2212\/\u2212) mouse spinal cord indicates widespread neuropathology","volume":"48","author":"Turner","year":"2016","journal-title":"Physiol. Genomics."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1165\/rcmb.2014-0374OC","article-title":"Stimulation of Respiratory Motor Output and Ventilation in a Murine Model of Pompe Disease by Ampakines","volume":"53","author":"ElMallah","year":"2015","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"15007","DOI":"10.1038\/mtm.2015.7","article-title":"Comparative impact of AAV and enzyme replacement therapy on respiratory and cardiac function in adult Pompe mice","volume":"2","author":"Falk","year":"2015","journal-title":"Mol. Ther. Methods.Clin. Dev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/hmg\/ddu476","article-title":"Peripheral nerve and neuromuscular junction pathology in Pompe disease","volume":"24","author":"Falk","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.omtm.2019.08.009","article-title":"AAV Gene Therapy Utilizing Glycosylation-Independent Lysosomal Targeting Tagged GAA in the Hypoglossal Motor System of Pompe Mice","volume":"15","author":"Doyle","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.resp.2016.02.007","article-title":"Neuropathology in respiratory-related motoneurons in young Pompe (Gaa(\u2212\/\u2212)) mice","volume":"227","author":"Turner","year":"2016","journal-title":"Respir. Physiol. Neurobiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1073\/pnas.0902534106","article-title":"Neural deficits contribute to respiratory insufficiency in Pompe disease","volume":"106","author":"DeRuisseau","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/hmg\/10.19.2039","article-title":"Conditional tissue-specific expression of the acid alpha-glucosidase (GAA) gene in the GAA knockout mice: Implications for therapy","volume":"10","author":"Raben","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/hum.2018.016","article-title":"Systemic Delivery of AAVB1-GAA Clears Glycogen and Prolongs Survival in a Mouse Model of Pompe Disease","volume":"30","author":"Keeler","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Puzzo, F., Colella, P., Biferi, M.G., Bali, D., Paulk, N.K., Vidal, P., Collaud, F., Simon-Sola, M., Charles, S., and Hardet, R. (2017). Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid alpha-glucosidase. Sci. Transl. Med., 9.","DOI":"10.1126\/scitranslmed.aam6375"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bbrc.2006.09.133","article-title":"Hyaluronidase increases the biodistribution of acid alpha-1,4 glucosidase in the muscle of Pompe disease mice: An approach to enhance the efficacy of enzyme replacement therapy","volume":"350","author":"Matalon","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ymthe.2005.04.024","article-title":"Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II","volume":"12","author":"Franco","year":"2005","journal-title":"Mol. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jgm.660","article-title":"Glycogen storage in multiple muscles of old GSD-II mice can be rapidly cleared after a single intravenous injection with a modified adenoviral vector expressing hGAA","volume":"7","author":"Xu","year":"2005","journal-title":"J. Gene Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ab.2011.12.026","article-title":"Mass spectrometric quantification of glycogen to assess primary substrate accumulation in the Pompe mouse","volume":"421","author":"Fuller","year":"2012","journal-title":"Anal. Biochem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1242\/dev.01169","article-title":"Rescue of enzyme deficiency in embryonic diaphragm in a mouse model of metabolic myopathy: Pompe disease","volume":"131","author":"Rucker","year":"2004","journal-title":"Development"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1096\/fj.13-244202","article-title":"Adjunctive beta2-agonist treatment reduces glycogen independently of receptor-mediated acid alpha-glucosidase uptake in the limb muscles of mice with Pompe disease","volume":"28","author":"Farah","year":"2014","journal-title":"FASEB J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1038\/mtna.2014.57","article-title":"Antisense Oligonucleotide-mediated Suppression of Muscle Glycogen Synthase 1 Synthesis as an Approach for Substrate Reduction Therapy of Pompe Disease","volume":"3","author":"Clayton","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.omtm.2016.12.010","article-title":"Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction","volume":"4","author":"Han","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/mt.2009.305","article-title":"Gel-mediated delivery of AAV1 vectors corrects ventilatory function in Pompe mice with established disease","volume":"18","author":"Mah","year":"2010","journal-title":"Mol. Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.mt.6300100","article-title":"Physiological correction of Pompe disease by systemic delivery of adeno-associated virus serotype 1 vectors","volume":"15","author":"Mah","year":"2007","journal-title":"Mol. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/mt.2011.214","article-title":"Spinal delivery of AAV vector restores enzyme activity and increases ventilation in Pompe mice","volume":"20","author":"Qiu","year":"2012","journal-title":"Mol. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1007\/s12035-017-0763-4","article-title":"A Neuron-Specific Gene Therapy Relieves Motor Deficits in Pompe Disease Mice","volume":"55","author":"Lee","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.omtm.2019.01.006","article-title":"Intravenous Injection of an AAV-PHP.B Vector Encoding Human Acid alpha-Glucosidase Rescues Both Muscle and CNS Defects in Murine Pompe Disease","volume":"12","author":"Lim","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fphys.2011.00031","article-title":"Hypoglossal neuropathology and respiratory activity in pompe mice","volume":"2","author":"Lee","year":"2011","journal-title":"Front. Physiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"L873","DOI":"10.1152\/ajplung.00568.2016","article-title":"Airway smooth muscle dysfunction in Pompe (Gaa(\u2212\/\u2212)) mice","volume":"312","author":"Keeler","year":"2017","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"R187","DOI":"10.1152\/ajpregu.00054.2013","article-title":"C1 neurons: The body\u2019s EMTs","volume":"305","author":"Guyenet","year":"2013","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.resp.2017.07.001","article-title":"Catecholaminergic A1\/C1 neurons contribute to the maintenance of upper airway muscle tone but may not participate in NREM sleep-related depression of these muscles","volume":"244","author":"Rukhadze","year":"2017","journal-title":"Respir. Physio.l Neurobiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/jimd.12101","article-title":"AAV9 gene replacement therapy for respiratory insufficiency in very-long chain acyl-CoA dehydrogenase deficiency","volume":"42","author":"Zieger","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1124\/jpet.116.235952","article-title":"Reveglucosidase alfa (BMN 701), an IGF2-Tagged rhAcid alpha-Glucosidase, Improves Respiratory Functional Parameters in a Murine Model of Pompe Disease","volume":"360","author":"Peng","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_72","first-page":"133","article-title":"Comparisons of Infant and Adult Mice Reveal Age Effects for Liver Depot Gene Therapy in Pompe Disease","volume":"17","author":"Han","year":"2020","journal-title":"Mol. Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1152\/jn.00479.2015","article-title":"Power spectral analysis of hypoglossal nerve activity during intermittent hypoxia-induced long-term facilitation in mice","volume":"115","author":"ElMallah","year":"2016","journal-title":"J. Neurophysiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.nmd.2016.05.018","article-title":"Progression from respiratory dysfunction to failure in late-onset Pompe disease","volume":"26","author":"Berger","year":"2016","journal-title":"Neuromuscul. Disord."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2016.12.004","article-title":"The emerging phenotype of late-onset Pompe disease: A systematic literature review","volume":"120","author":"Chan","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/ppul.24621","article-title":"Pulmonary outcome measures in long-term survivors of infantile Pompe disease on enzyme replacement therapy: A case series","volume":"55","author":"ElMallah","year":"2020","journal-title":"Pediatr. Pulmonol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"19006","DOI":"10.1038\/s41598-019-54314-8","article-title":"Dynamic respiratory muscle function in late-onset Pompe disease","volume":"9","author":"Smith","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ymgme.2019.05.001","article-title":"Respiratory muscle training (RMT) in late-onset Pompe disease (LOPD): A protocol for a sham-controlled clinical trial","volume":"127","author":"Jones","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1007\/s00415-019-09455-1","article-title":"Bright tongue sign in patients with late-onset Pompe disease","volume":"266","author":"Karam","year":"2019","journal-title":"J. Neurol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1212\/WNL.57.7.1290","article-title":"Sleep-disordered breathing and respiratory failure in acid maltase deficiency","volume":"57","author":"Mellies","year":"2001","journal-title":"Neurology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.resp.2013.06.007","article-title":"The respiratory neuromuscular system in Pompe disease","volume":"189","author":"Fuller","year":"2013","journal-title":"Respir. Physiol. Neurobiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"289","DOI":"10.21037\/atm.2019.04.49","article-title":"An emerging phenotype of central nervous system involvement in Pompe disease: From bench to bedside and beyond","volume":"7","author":"Korlimarla","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ymgme.2017.10.005","article-title":"Neuroimaging findings in infantile Pompe patients treated with enzyme replacement therapy","volume":"123","author":"McIntosh","year":"2018","journal-title":"Mol. Genet Metab."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/8904_2015_426","article-title":"Postmortem Findings and Clinical Correlates in Individuals with Infantile-Onset Pompe Disease","volume":"23","author":"Pena","year":"2015","journal-title":"JIMD Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1540\/jsmr.54.100","article-title":"The impact of Pompe disease on smooth muscle: A review","volume":"54","author":"McCall","year":"2018","journal-title":"J. Smooth Muscle Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00687878","article-title":"Pompe\u2019s disease: An inborn lysosomal disorder with storage of glycogen. A study of brain and striated muscle","volume":"23","author":"Martin","year":"1973","journal-title":"Acta Neuropathol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/mus.880100311","article-title":"The pattern of involvement of adult-onset acid maltase deficiency at autopsy","volume":"10","author":"Swash","year":"1987","journal-title":"Muscle Nerve"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ymgme.2012.05.007","article-title":"Autopsy findings in late-onset Pompe disease: A case report and systematic review of the literature","volume":"106","author":"Proia","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0022-510X(90)90258-O","article-title":"Aneurysms and vacuolar degeneration of cerebral arteries in late-onset acid maltase deficiency","volume":"98","author":"Kretzschmar","year":"1990","journal-title":"J. Neurol. Sci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00313272","article-title":"Acid maltase deficiency in non-identical adult twins. A morphological and biochemical study","volume":"213","author":"Martin","year":"1976","journal-title":"J. Neurol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1183\/09031936.00169011","article-title":"Supine volume drop and diaphragmatic function in adults with Pompe disease","volume":"39","author":"Prigent","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2522\/ptj.20150122","article-title":"Diaphragm Pacing as a Rehabilitative Tool for Patients With Pompe Disease Who Are Ventilator-Dependent: Case Series","volume":"96","author":"Smith","year":"2016","journal-title":"Phys. Ther."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00005072-197107000-00008","article-title":"Nervous system in Pompe\u2019s disease. Ultrastructure and biochemistry","volume":"30","author":"Gambetti","year":"1971","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_94","first-page":"379","article-title":"Infantile-onset glycogen storage disease type II (Pompe disease): Report of a case with genetic diagnosis and pathological findings","volume":"27","author":"Teng","year":"2004","journal-title":"Chang Gung Med. J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00005072-196501000-00008","article-title":"Pompe\u2019s Disease (Diffuse Glycogenosis) with Neuronal Storage","volume":"24","author":"Mancall","year":"1965","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1378\/chest.105.3.947","article-title":"Obstructive sleep apnea syndrome in acid maltase deficiency","volume":"105","author":"Margolis","year":"1994","journal-title":"Chest"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Kansagra, S., Austin, S., Dearmey, S., Kishnani, P.S., and Kravitz, R.M. (2013). Polysomnographic findings in infantile Pompe disease. Am. J. Med. Genet. A.","DOI":"10.1002\/ajmg.a.36227"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/NEN.0b013e3181815994","article-title":"Temporal neuropathologic and behavioral phenotype of 6neo\/6neo Pompe disease mice","volume":"67","author":"Sidman","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/hmg\/7.1.53","article-title":"Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease","volume":"7","author":"Bijvoet","year":"1998","journal-title":"Hum. Mol. Genet."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/6\/2256\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:11:14Z","timestamp":1760173874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/6\/2256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,24]]},"references-count":99,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["ijms21062256"],"URL":"https:\/\/doi.org\/10.3390\/ijms21062256","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints202001.0256.v1","asserted-by":"object"}]},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,24]]}}}